News for Healthier Living

Low Dose of Hydroxychloroquine Is Associated with Reduced COVID-19 Mortality: A Multicenter Study in China

This multicenter study confirms the clinical value of low-dose hydroxychloroquine in reducing the mortality of COVID-19 patients and preventing major organ injuries. This finding provides key evidence for resolving the controversy over hydroxychloroquine treatment and lays a foundation for formulating optimized dosage regimens.

September 30, 2025


October 6 2025

October 5 2025

October 4 2025

October 3 2025

October 2 2025

October 1 2025

September 30 2025

September 29 2025

September 28 2025

September 27 2025

September 26 2025

September 25 2025

September 24 2025

September 23 2025

September 22 2025